Back
DXP Enterprises 10K Form
Buy
74
DXPE
DXP Enterprises
Last Price:
$78.99
Seasonality Move:
41.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | DXPE/DXP Enterprises Quarterly |
2023-11-09 | 10Q | DXPE/DXP Enterprises Quarterly |
2023-08-09 | 10Q | DXPE/DXP Enterprises Quarterly |
2023-05-15 | 10Q | DXPE/DXP Enterprises Quarterly |
2022-11-09 | 10Q | DXPE/DXP Enterprises Quarterly |
2022-08-09 | 10Q | DXPE/DXP Enterprises Quarterly |
Receive DXPE News And Ratings
See the #1 stock for the next 7 days that we like better than DXPE
DXPE Financial Statistics
Sales & Book Value
Annual Sales: | $1.7B |
---|---|
Cash Flow: | $24.4M |
Price / Cash Flow: | 14.47 |
Annual Sales: | $25.64 |
Price / Book: | 3.08 |
Profitability
EPS (TTM): | 3.89000 |
---|---|
Net Income (TTM): | $65.1M |
Gross Margin: | $505.3M |
Return on Equity: | 17.08% |
Return on Assets: | 5.59% |
DXP Enterprises Earnings Forecast
Key DXP Enterprises Financial Ratios
-
The Gross Profit Margin over the past 28 years for DXPE is 30.10%.
-
The Selling, General & Administrative Expenses for DXPE have been equal to 21.84% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 77.23% of Operating Income.
-
The Net Earning history of DXPE is 4.10% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 20 years.
DXP Enterprises Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Trading Companies & Distributors |
Sector: | Industrials |
Current Symbol: | DXPE |
CUSIP: | 233377 |
Website: | dxpe.com |
Debt
Debt-to-Equity Ratio: | 1.3 |
---|---|
Current Ratio: | 2.22 |
Quick Ratio: | 1.69 |
Price-to-Earnings
Trailing P/E Ratio: | 20.28 |
---|---|
Forward P/E Ratio: | 18.3 |
DXPE Technical Analysis vs Fundamental Analysis
Buy
74
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy or a Sell?
-
DXP Enterprises stock is rated a BuyThe current DXP Enterprises [DXPE] share price is $78.89. The Score for DXPE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.